You have no items in your shopping basket.
Mon - Fri 9AM - 5PM
024 7610 0090
Flu cases are rising sharply across England, prompting the NHS to issue an urgent call for millions to get vaccinated before winter peaks. In this blog, Dr Richard Dune examines the “flu jab SOS” campaign, which opens 2.4 million appointments to protect vulnerable groups and ease seasonal pressures on hospitals. He explores how early vaccination, data-driven planning, and cross-sector collaboration can strengthen winter resilience across health and social care. The message is clear: prevention, preparation, and partnership remain vital to protecting both patients and the NHS this winter.
12
Nov
The NHS has issued an urgent call for people in England to get their flu jab now, warning that the worst of the winter season is only weeks away. With flu cases already three times higher than at this time last year and hospital pressures mounting, health officials are urging...
Read more >England’s sexual and reproductive health services are facing a critical moment after more than a decade without a national plan. In this blog, Dr Richard Dune examines the Health and Social Care Committee’s call for renewed leadership, sustainable funding, and a coordinated national strategy to rebuild a system that has been fragmented, underfunded, and overlooked. He highlights key recommendations on workforce development, integrated care, stronger data, and public education, reflecting wider lessons for health and social care providers on the importance of prevention, accountability, and collaboration in achieving lasting reform.
10
Nov
England’s sexual and reproductive health services have been left undervalued, underfunded, and fragmented after more than a decade without a national plan. That is the stark message from the Health and Social Care Committee, which has written to the Department of Health and Social Care (DHSC) with urgent recommendations for...
Read more >Thousands of men in England are set to benefit from a new NICE-approved prostate cancer treatment that offers life-extending results with fewer side effects. In this blog, Dr Richard Dune explores the approval of darolutamide combined with androgen deprivation therapy, a milestone that halves the risk of death for men with advanced prostate cancer who cannot tolerate chemotherapy. He examines what this means for patients, professionals, and the wider health system from improving equity and access to embedding new NICE guidance into governance, compliance, and workforce training across the NHS.
29
Oct
Thousands of men across England are set to benefit from a newly approved, better-tolerated prostate cancer treatment. The National Institute for Health and Care Excellence (NICE) has recommended darolutamide (Nubeqa), a hormone-blocking drug, in combination with androgen deprivation therapy (ADT) for men with metastatic hormone-sensitive prostate cancer (mHSPC) who are...
Read more >
27
Jun
The Voluntary, Community, and Social Enterprise (VCSE) sector plays a pivotal role in delivering more joined-up, equitable, and innovative care. Whether through grassroots support, social prescribing, or strategic partnerships, VCSE organisations are essential partners in Integrated Care Systems (ICSs) and Provider Collaboratives. In this blog, Dr Richard Dune explores their...
Read more >
26
Jun
Integrated Care Systems (ICSs) represent one of the most significant NHS reforms in a generation. These place-based partnerships aim to transform how health and social care services are planned, commissioned, and delivered across England. The goal is clear: join up services, improve population health, reduce health inequalities, and enable more...
Read more >
